FDA.reportPublic FDA data

Nuclear matrix protein 22 IVD, reagent

Definition
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of nuclear matrix protein 22 in a clinical specimen.
GUDID devices
1
Last updated
2023-09-14 08:46:09

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
10811877010637Alere NMP22® Urine Collection Kit Alere Scarborough, Inc.D2100E2014-09-01